نتائج البحث - "Walter M. Stadler"

1

Prevalence of potential interactions of medications, including herbs and supplements, before, during, and after chemotherapy in patients with breast and prostate cancer

المؤلفون: Raffi Tchekmedyian, Jimin Wu, Connie To, Olufunmilayo I. Olopade, Russell Z. Szmulewitz, Walter M. Stadler, Jamie H. Von Roenn, Holly M. Holmes, Steven To, Nancy Kwon, Richard T. Lee

المصدر: Cancer. 127:1827-1835

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fef8184d9e29fce49be6d6f83decbe27
https://doi.org/10.1002/cncr.33324

View record at Wiley

2

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

المؤلفون: Rana R. McKay, Lauren C. Harshman, David F. McDermott, Benjamin L. Maughan, Tracy L. Rose, Christos Kyriakopoulos, Bradley Alexander McGregor, Toni K. Choueiri, Walter M. Stadler, Yousef Zakharia, David A. Braun, Xiao Wei, Wanling Xie

المصدر: J Clin Oncol

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17ab5413583214482f6b3dd40cfebae0
https://doi.org/10.1200/jco.20.02295

3

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)

المؤلفون: Glenn Liu, Miguel A. Villalona-Calero, Jorge A. Garcia, John J. Wright, Susan Geyer, Walter M. Stadler, Paul Monk, Ying Huang, Roberto Pili, Russell Z. Szmulewitz, Robert Dreicer, Amir Mortazavi, James L. Wade, Nancy A. Dawson, Shilpa Gupta, Saby George

المصدر: Investigational New Drugs

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, medicine.medical_specialty, Castration resistant, Neutropenia, Phase II Studies, Placebo-controlled study, Antineoplastic Agents, Placebo, Asymptomatic, Disease-Free Survival, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Double-Blind Method, Median follow-up, Internal medicine, Bradycardia, medicine, Humans, Pharmacology (medical), Progression-free survival, Tivantinib, Protein Kinase Inhibitors, Cancer, Aged, Aged, 80 and over, Pharmacology, business.industry, Prostate, Middle Aged, Proto-Oncogene Proteins c-met, medicine.disease, Pyrrolidinones, Prostatic Neoplasms, Castration-Resistant, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Quinolines, medicine.symptom, business, Febrile neutropenia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280b8d77f3ca23429bf71834133ae70e
https://doi.org/10.1007/s10637-018-0630-9

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

4

A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study

المؤلفون: Ryan J. Brisson, Sara Kochanny, Everett E. Vokes, Bethany G. Sleckman, Tanguy Y. Seiwert, Daniel M. Anderson, Francis P. Worden, Walter M. Stadler, Kevin Wood, James L. Wade, Theodore Karrison, Douglas Adkins

المصدر: CancerReferences. 126(14)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Phases of clinical research, Cetuximab, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, 030212 general & internal medicine, neoplasms, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Sirolimus, Leukopenia, business.industry, Squamous Cell Carcinoma of Head and Neck, TOR Serine-Threonine Kinases, Head and neck cancer, Middle Aged, medicine.disease, Head and neck squamous-cell carcinoma, Temsirolimus, Progression-Free Survival, ErbB Receptors, Tolerability, Drug Resistance, Neoplasm, Head and Neck Neoplasms, 030220 oncology & carcinogenesis, Female, medicine.symptom, Neoplasm Recurrence, Local, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::194826d140e7cd9c12390a5aae9dd979
https://pubmed.ncbi.nlm.nih.gov/32365226

View record at Wiley

5

Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations

المؤلفون: Yusuke Nakamura, Theodore Karrison, Noura Choudhury, Walter M. Stadler, Peter H. O'Donnell, Carrie Fitzpatrick, James L. Wade, Tatjana Antic, Kai Lee Yap, Alexa Campanile

المصدر: Journal of Clinical Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb2d8bcd1aa46a19fe0aeb0c9a483cf
https://doi.org/10.1200/jco.2015.66.3047

6

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial

المصدر: The Lancet Oncology. 17:378-388

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Indoles, Population, 030232 urology & nephrology, Kaplan-Meier Estimate, Chromophobe cell, Gastroenterology, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, Confidence Intervals, Sunitinib, Clinical endpoint, medicine, Carcinoma, Humans, Neoplasm Invasiveness, Pyrroles, Everolimus, Neoplasm Metastasis, education, Carcinoma, Renal Cell, Aged, Neoplasm Staging, Proportional Hazards Models, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Middle Aged, medicine.disease, Survival Analysis, Kidney Neoplasms, Surgery, Clear cell renal cell carcinoma, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Female, business, Follow-Up Studies, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c1606ba98af97de53c79d48f33780cb
https://doi.org/10.1016/s1470-2045(15)00515-x

View record from ScienceDirect

Find this article in full text from ProQuest

Full Text via ClinicalKey

7

Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2

المؤلفون: Michael R. Bishop, Parameswaran Venugopal, Aaron P. Rapoport, James Godfrey, Walter M. Stadler, Reem Karmali, Kenneth S. Cohen, Chadi Nabhan, Justin Kline, Theodore Karrison, Sonali M. Smith

المصدر: Cancer. 125(11)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Cyclophosphamide, Maximum Tolerated Dose, medicine.medical_treatment, Aggressive lymphoma, Drug Administration Schedule, Translocation, Genetic, Maintenance Chemotherapy, Proto-Oncogene Proteins c-myc, 03 medical and health sciences, 0302 clinical medicine, Chemoimmunotherapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 030212 general & internal medicine, EPOCH (chemotherapy), Lenalidomide, Aged, Etoposide, Aged, 80 and over, Chemotherapy, business.industry, Common Terminology Criteria for Adverse Events, Middle Aged, Treatment Outcome, Proto-Oncogene Proteins c-bcl-2, Doxorubicin, Vincristine, 030220 oncology & carcinogenesis, Feasibility Studies, Prednisone, Rituximab, Female, Lymphoma, Large B-Cell, Diffuse, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cc48c14fa9c35252fd4a063cfacc919
https://pubmed.ncbi.nlm.nih.gov/30707764

View record at Wiley

8

Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C

المؤلفون: Michael J, Jelinek, Sang Mee, Lee, Alicia, Wyche Okpareke, Claudia, Wing, Jay L, Koyner, Patrick T, Murray, Walter M, Stadler, Peter H, O' Donnell

المصدر: Clinical and Translational Science

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::a1e91f933e53d874abdb28bf1766cfbf
https://pubmed.ncbi.nlm.nih.gov/29691991

View record at Wiley

Find this article in full text from ProQuest

9

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

المصدر: Nature medicine. 24(6)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Carcinoma, Sunitinib, Humans, Carcinoma, Renal Cell, Aged, Aged, 80 and over, business.industry, Gene Expression Profiling, Antibodies, Monoclonal, General Medicine, Immunotherapy, Middle Aged, medicine.disease, Immune checkpoint, Kidney Neoplasms, Angiogenesis inhibitor, Gene Expression Regulation, Neoplastic, 030104 developmental biology, Treatment Outcome, 030220 oncology & carcinogenesis, Mutation, Female, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::473ccd225ada7c2586204155b123a86b
https://pubmed.ncbi.nlm.nih.gov/30291359

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

10

Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis

المؤلفون: Matthew R, Danzig, Katherine, Mallin, James M, McKiernan, Walter M, Stadler, Srikala S, Sridhar, Todd M, Morgan, Bernard H, Bochner, Cheryl T, Lee

المصدر: Cancer

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Carcinoma, Transitional Cell, Middle Aged, Prognosis, Nephroureterectomy, Survival Analysis, Kidney Neoplasms, Article, Young Adult, Lymphatic Metastasis, Humans, Female, Kidney Pelvis, Neoplasm Recurrence, Local, Aged, Follow-Up Studies, Lymphatic Vessels, Neoplasm Staging, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::d41eca9ab3f6b395266a9f5ef3a07dcd
https://pubmed.ncbi.nlm.nih.gov/29624636

View record at Wiley

تنقيح النتائج